New imaging probes to track cell fate: reporter genes in stem cell research |
| |
Authors: | Piotr Jurgielewicz Stefan Harmsen Elizabeth Wei Michael H. Bachmann Richard Ting Omer Aras |
| |
Affiliation: | 1.Pennsylvania State University College of Medicine,Hershey,USA;2.Department of Pediatrics,Stanford University,Stanford,USA;3.Brown University,Providence,USA;4.Department of Radiology, Weill Cornell Medicine,Weill Cornell Medical College,New York,USA;5.Department of Radiology,Memorial Sloan Kettering Cancer Center,New York,USA |
| |
Abstract: | Cell fate is a concept used to describe the differentiation and development of a cell in its organismal context over time. It is important in the field of regenerative medicine, where stem cell therapy holds much promise but is limited by our ability to assess its efficacy, which is mainly due to the inability to monitor what happens to the cells upon engraftment to the damaged tissue. Currently, several imaging modalities can be used to track cells in the clinical setting; however, they do not satisfy many of the criteria necessary to accurately assess several aspects of cell fate. In recent years, reporter genes have become a popular option for tracking transplanted cells, via various imaging modalities in small mammalian animal models. This review article examines the reporter gene strategies used in imaging modalities such as MRI, SPECT/PET, Optoacoustic and Bioluminescence Imaging. Strengths and limitations of the use of reporter genes in each modality are discussed. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|